World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03055585
Date of registration: 14/02/2017
Prospective Registration: Yes
Primary sponsor: Gadjah Mada University
Public title: Applying Wolbachia to Eliminate Dengue AWED
Scientific title: Applying Wolbachia to Eliminate Dengue (AWED): A Non-blinded Cluster Randomised Controlled Trial to Assess the Efficacy of Wolbachia-infected Mosquito Deployments to Reduce Dengue Incidence in Yogyakarta, Indonesia
Date of first enrolment: November 8, 2017
Target sample size: 8173
Recruitment status: Terminated
URL:  https://clinicaltrials.gov/show/NCT03055585
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Indonesia
Contacts
Name:     Adi Utarini, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Faculty of Medicine, Universitas Gadjah Mada
Key inclusion & exclusion criteria

Inclusion Criteria:

- Fever (either self-reported or objectively measured, e.g. (tympanic membrane
temperature =38oC)) of 1-4 days duration, and where onset was prior to the day of
presentation

- Aged between 3-45 years old

- Resided in the study area every night for the 10 days preceding illness onset

Exclusion Criteria:

- Localising features suggestive of a specific diagnosis other than an arboviral
infection e.g. severe diarrhea, otitis, pneumonia

- Prior enrollment in the study within the previous 4 weeks



Age minimum: 3 Years
Age maximum: 45 Years
Gender: All
Health Condition(s) or Problem(s) studied
Dengue
Zika Virus Infection
Chikungunya Fever
Intervention(s)
Biological: Wolbachia-infected Aedes aegypti mosquitoes
Other: standard practice dengue control
Primary Outcome(s)
Relative risk of dengue in Wolbachia-treated versus untreated clusters [Time Frame: Up to 36 months participant enrolment]
Secondary Outcome(s)
Relative risk of serotype-specific dengue in Wolbachia-treated versus untreated clusters [Time Frame: Up to 36 months participant enrolment]
Relative risk of Zika in Wolbachia-treated versus untreated clusters [Time Frame: Up to 36 months participant enrolment]
Relative risk of Chikungunya in Wolbachia-treated versus untreated clusters [Time Frame: Up to 36 months participant enrolment]
Secondary ID(s)
UGM_KE/FK/105/EC
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
The Tahija Foundation
Monash University
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history